Back to Search
Start Over
Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease
- Source :
- Atherosclerosis, 231(2), 308-314. Elsevier Ireland Ltd
- Publication Year :
- 2013
-
Abstract
- Low high-density lipoprotein (HDL) cholesterol is well-established as a negative risk factor for coronary artery disease (CAD) and its anti-oxidant property has been attributed mainly to the HDL-bound enzyme paraoxonase-1 (PON-1). Recently, myeloperoxidase (MPO), a pro-oxidant enzyme released from activated neutrophils, has been shown to alter the atheroprotective function of HDL to a dysfunctional form. This study investigated the relationship between plasma MPO and serum PON-1 levels in patients with stable (SAP) and unstable angina pectoris (UAP). Plasma MPO levels and serum PON-1 concentration/activity were measured in patients with SAP (n = 226), UAP (n = 151) and in control subjects (n = 99). Plasma MPO levels in UAP patients were significantly higher than those in SAP patients or in control subjects (UAP, 21.6[16.7-44.6]; SAP, 19.3[15.7-29.1]; control, 15.9[14.7-18.7] ng/mL; P < 0.0001). Serum PON-1 concentrations in UAP and SAP patients were significantly lower than those in control subjects (UAP, 55.6[45.9-69.7]; SAP, 55.0[46.9-64.9]; control, 62.5[51.1-78.8] μg/mL; P = 0.0002). Plasma MPO levels showed a weak inverse correlation with serum PON-1 concentrations in all subjects (R = -0.163, P < 0.0005). Moreover, in women, plasma MPO levels showed a significant inverse correlation with serum PON-1 concentrations and PON-arylesterase activity in SAP (concentration: R = -0.537, P < 0.0001; arylesterase-activity: R = -0.469, P < 0.001) and UAP (concentration: R = -0.340, P < 0.05; arylesterase-activity: R = -0.350, P < 0.05) patients, but not in men. This study demonstrates that plasma MPO levels have a significant inverse correlation with PON-1 levels, especially in women, in SAP and UAP patients, and suggests that an imbalance between pro-oxidants and anti-oxidants may contribute to the progression of coronary plaque instability
- Subjects :
- Male
medicine.medical_specialty
Enzyme-Linked Immunosorbent Assay
Coronary Artery Disease
Antioxidants
Diabetes Complications
Angina
Coronary artery disease
chemistry.chemical_compound
Sex Factors
Internal medicine
medicine
Humans
Angina, Stable
Angina, Unstable
Aged
Peroxidase
Polymorphism, Genetic
biology
Aryldialkylphosphatase
Cholesterol
Unstable angina
business.industry
Paraoxonase
Middle Aged
Oxidants
medicine.disease
Oxidative Stress
Endocrinology
chemistry
Case-Control Studies
Myeloperoxidase
biology.protein
Female
Lipoproteins, HDL
Cardiology and Cardiovascular Medicine
business
Biomarkers
Lipoprotein
Subjects
Details
- Language :
- English
- ISSN :
- 00219150
- Volume :
- 231
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- Atherosclerosis
- Accession number :
- edsair.doi.dedup.....224f889d41b277277dedceb93ccea1fc
- Full Text :
- https://doi.org/10.1016/j.atherosclerosis.2013.08.037